AlloVir Inc’s recent filing unveils that its Chief Executive Officer Brainard Diana unloaded Company’s shares for reported $9176.0 on Nov 05 ’24. In the deal valued at $0.86 per share,10,609 shares were sold. As a result of this transaction, Brainard Diana now holds 732,069 shares worth roughly $0.4 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Miller Edward sold 2,272 shares, generating $1,965 in total proceeds. Upon selling the shares at $0.86, the General Counsel now owns 211,931 shares.
Before that, Hagen Brett R sold 1,655 shares. AlloVir Inc shares valued at $1,431 were divested by the Chief Accounting Officer at a price of $0.86 per share. As a result of the transaction, Hagen Brett R now holds 69,060 shares, worth roughly $37292.4.
BofA Securities downgraded its AlloVir Inc [ALVR] rating to an Underperform from a a Buy in a research note published on December 26, 2023; the price target was decreased to $1 from $17. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late December from “an Overweight” to “a Neutral”. Leerink Partners also remained covering ALVR and has decreased its forecast on December 22, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on December 22, 2023. It rated ALVR as “an Underweight” which previously was an “an Overweight”.
Price Performance Review of ALVR
On Tuesday, AlloVir Inc [NASDAQ:ALVR] saw its stock fall -26.73% to $0.54. Over the last five days, the stock has lost -45.30%. AlloVir Inc shares have fallen nearly -20.34% since the year began. Nevertheless, the stocks have fallen -61.87% over the past one year. While a 52-week high of $2.48 was reached on 11/04/24, a 52-week low of $0.58 was recorded on 11/12/24. SMA at 50 days reached $0.8008, while 200 days put it at $0.7643.
Levels Of Support And Resistance For ALVR Stock
The 24-hour chart illustrates a support level at 0.4744, which if violated will result in even more drops to 0.4073. On the upside, there is a resistance level at 0.6643. A further resistance level may holdings at 0.7871. The Relative Strength Index (RSI) on the 14-day chart is 34.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.2153, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.81%. Stochastics %K at 12.37% indicates the stock is a buying.
How much short interest is there in AlloVir Inc?
A steep rise in short interest was recorded in AlloVir Inc stocks on 2024-10-31, dropping by -1.55 million shares to a total of 3.95 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 5.5 million shares. There was a decline of -39.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 18, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $17 price target.
